The 5th IFPMA Asian Regulatory Conference 2OO8Held in Kuala Lumpur, Malaysia, the IFPMA's latest conference on regulatory affairs in Asia looked at the region's place in global harmonisation efforts, good regulatory practices, and how to assure quality. Alan Chalmers reports.

摘要

The 5th IFPMA Asian Regulatory Conference, held this year in Malaysia, was organised by the International Federation of Pharmaceutical Manufacturers Associations in co-operation with the Ministry of Health of Malaysia, in collaboration with the World Health Organization and with support from the Pharmaceutical Association of Malaysia (PhAMA). It was attended by over 300 delegates from regulatory authorities, international organisations and pharmaceutical companies. Speakers, discussants and participants had been invited from the health ministries and regulatory authorities of all Asian countries, as had expert representatives from all the International Conference on Harmonisation regions, international organisations and the pharmaceutical industry. The Organising Committee chaired by Alistair Davidson collaborated closely with Odette Morin, director of regulatory and scientific affairs at the IFPMA, and her team.Organization and with support from the Pharmaceutical Association of Malaysia (PhAMA). It was attended by over 300 delegates from regulatory authorities, international organisations and pharmaceutical companies. Speakers, discussants and participants had been invited from the health ministries and regulatory authorities of all Asian countries, as had expert representatives from all the International Conference on Harmonisation regions, international organisations and the pharmaceutical industry. The Organising Committee chaired by Alistair Davidson collaborated closely with Odette Morin, director of regulatory and scientific affairs at the IFPMA, and her team.